Endo Claims Opana Generic Versions Ripe For Misuse, Abuse
Endo Pharmaceuticals Inc. on Friday urged a judge to force the U.S. Food and Drug Administration to determine whether the drugmaker voluntarily yanked the original version of its Opana ER painkiller...To view the full article, register now.
Already a subscriber? Click here to view full article